Clinical involvement and protein expression in individuals with the FMR1 premutation

American Journal of Medical Genetics

Volumn 91, Issue 2, 2000, Pages 144-152

  Tassone, F ^a   Hagerman, R J ^a,b   Taylor, A K ^c   Mills, J B ^a   Harris, S W ^b   Gane, L W ^b   Hagerman, Paul ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c Kimball Genetics Inc   (United States)

Author keywords

FMRP; Fragile X syndrome; Immunocytochemistry; Mental retardation; Trinucleotide repeat

Indexed keywords

ADOLESCENT; ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; FEMALE; FRAGILE X SYNDROME; GENE FUNCTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LEARNING DISORDER; MALE; MENTAL DEFICIENCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRINUCLEOTIDE REPEAT;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; ALLELES; BEHAVIORAL SYMPTOMS; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; FAMILY HEALTH; FATHERS; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HETEROZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MOTHERS; NERVE TISSUE PROTEINS; PHENOTYPE; RNA, MESSENGER; RNA-BINDING PROTEINS; TRINUCLEOTIDE REPEATS;

EID: 0034016083     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(20000313)91:2<144::AID-AJMG14>3.0.CO;2-V     Document Type: Article

References (56)

1. Allingham-Hawkins DJ, Brown CA, Babul R, Chitayat D, Krekewich K, Humphries T, Ray PN, Teshima IE. 1996. Tissue-specific methylation differences and cognitive function in fragile X premutation females. Am J Med Genet 64:329-333.
2. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, Hudson R, Gorwill H, Nolin SL, Glicksman A, Jenkins EC, Brown WT, Howard-Peebles PN, Becchi C, Cummings E, Fallon L, Seitz S, Black SH, Vianna-Morgante AM, Costa SS, Otto PA, Mingroni-Netto RC, Murray A, Webb J, Vieri F. 1999. Fragile X premutation is a significant risk factor for premature ovarian failure: the international collaborative POF in fragile X study-preliminary data. Am J Med Genet 83:322-325.
3. Brown WT, Houck GE Jr, Jeziorowska A, Levinson FN, Ding X, Dobkin C, Zhong N, Henderson J, Brooks SS, Jenkins EC. 1993. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 270:1569-1575.
4. Brown CA, Brasington CK, Grass FS. 1995. Paternal transmission of a full mutation in the FMR1 gene: identification of paternal CGG repeat sizes in multiple tissues. Am J Hum Genet 57(Suppl.):A335.
5. Conway GS, Hettiarachchi S, Murray A, Jacobs PA. 1995. Fragile X premutations in familial premature ovarian failure. Lancet 346:309-310.
6. de Graaff E, Willemsen R, Zhong N, de Die-Smulders CEM, Brown WT, Freling G, Oostra B. 1995. Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor. Am J Hum Genet 57:609-618.
7. de Vries BB, van den Ouweland AM, Mohkamsing S, Duivenvoorden HJ, Mol E, Gelsema K, van Rijn M, Halley DJ, Sandkuijl LA, Oostra BA, Tibben A, Niermeijer MF. 1997. Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group, Am J Hum Genet 61:660-667.
8. Devys D, Biancalana V, Rousseau F, Boue J, Mandel JL, Oberle I. 1992. Analysis of full fragile X mutations in fetal tissues and monozygotic twins indicate that abnormal methylation and somatic heterogeneity are established early in development. Am J Med Genet 43:208-216.
9. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL. 1993. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335-340.
10. Dobkin CS, Nolin SL, Cohen I, Sudhalter V, Bialer MG, Ding XH, Jenkins EC, Zhong N, Brown WT. 1996. Tissue differences in fragile X mosaics: mosaicism in blood cells may differ greatly from skin. Am J Med Genet 64:296-301.
11. Dorn MB, Mazzocco MM, Hagerman RJ. 1994. Behavioral and psychiatric disorders in adult male carriers of fragile X. J Am Acad Child Adolesc Psychiatry 33:256-264.
12. Feng Y, Lakkis L, Devys D, Warren ST. 1995a. Quantitative comparison of FMR1 gene expression in normal and premutation alleles. Am J Hum Genet 56:106-113.
13. Feng Y, Zhang F, Lokey LK, Chastain JL, Lakkis L, Eberhart D, Warren ST. 1995b. Translational suppression by trinucleotide repeat expansion at FMR1. Science 268:731-734.
14. Franke P, Maier W, Hautzinger M, Weiffenbach O, Gansicke M, Iwers B, Poustka F, Schwab SG, Froster U. 1996. Fragile-X carrier females: evidence for a distinct psychopathological phenotype? Am J Med Genet 64:334-339.
15. Franke P, Leboyer M, Gansicke M, Weiffenbach O, Biancalana V, Cornillet-Lefebre P, Croquette MF, Froster U, Schwab SG, Poustka F, Hautzinger M, Maier W. 1998. Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. Psychiatry Res 80:113-127.
16. Giovannucci Uzielli ML, Guarducci S, Lapi E, Cecconi A, Ricci U, Ricotti G, Biondi C, Scarselli B, Vieri F, Scarnato P, Gori F, Sereni A. 1999. Premature ovarian failure (POF) and fragile X premutation females: from POF to fragile X carrier. Identification, from fragile X carrier diagnosis to POF. Association data. Am J Med Genet 84:300-303.
17. Hagerman RJ. 1999. Neurodevelopmental disorders: diagnosis and treatment. Oxford: Oxford University Press, p 61-132.
18. Hagerman RJ, Hull CE, Safanda JF, Carpenter I, Staley LW, O'Connor, RA, Seydel C, Mazzocco MM, Snow K, Thibodeau SN. 1994. High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression. Am J Med Genet 51:298-308.
19. Hagerman RJ, Staley LW, O'Conner R, Lugenbeel K, Nelson D, McLean SD, Taylor A. 1996. Learning-disabled males with a fragile X CGG expansion in the upper premutation size range. Pediatrics 97:122-126.
20. Hull C, Hagerman RJ. 1993. A study of the physical, behavioral, and medical phenotype, including anthropometric measures, of females with fragile X syndrome. Am J Dis Child 147:1236-1241.
21. Kenneson A, Cramer DW, Warren ST. 1997. Fragile X premutations are not a major cause of early menopause. Am J Hum Genet 61:1362-1369.
22. Loesch DZ, Hay DA, Mulley J. 1994. Transmitting males and carrier females in fragile X-revisited. Am J Med Genet 51:392-399.
23. Loesch DZ, Hay DA, Sutherland GR, Howard-Peebles PN. 1987. Phenotypic variation in male-transmitted fragile X: genetic inferences. Am J Med Genet 27:401-417.
24. Maddalena A, Yadvish KN, Spence WC, Howard-Peebles PN. 1996. A fragile X mosaic male with a cryptic full mutation detected in epithelium but not in blood. Am J Med Genet 64:309-312.
25. Mazzocco MM, Pennington BF, Hagerman RJ. 1993. The neurocognitive phenotype of female carriers of fragile X: additional evidence for specificity. J Dev Behav Pediatr 14:328-335.
26. Moutou C, Vincent MC, Biancalana V, Mandel J-L. 1997. Transition from premutation to full mutation in fragile X syndrome is likely to be prezygotic. Hum Mol Genet 6:971-979.
27. Murphy DGM, Mentis MJ, Pietrini P, Grady GL, Moore CJ, Horwitz B, Hinton V, Dobkin CS, Schapiro MB, Rapoport SI. 1999. Premutation female carriers of fragile X syndrome: a pilot study on brain anatomy and metabolism. J Am Acad Child Adolesc Psychiatry 38:1294-1301.
28. Murray A, Macpherson JN, Pound MC, Sharrock A, Youings SA, Dennis NR, McKechnie N, Linehan P, Morton NE, Jacobs PA. 1997. The role of size, sequence and haplotype in the stability of FRAXA and FRAXE alleles during transmission. Hum Mol Genet 6:173-184.
29. Murray A, Webb J, Grimley S, Conway G, Jacobs P. 1998. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 35:637-640.
30. Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas MF, Mandel JL. 1991. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252: 1097-1102.
31. Partington MW, Moore DY, Turner GM. 1996. Confirmation of early menopause in fragile X carriers. Am J Med Genet 64:370-372.
32. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, Nelson DL. 1991. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822.
33. Reiss AL, Freund L, Abrams MT, Boehm C, Kazazian H. 1993. Neurobehavioral effects of the fragile X premutation in adult women: a controlled study. Am J Hum Genet 52:884-894.
34. Reyniers E, Martin J-J, Cras P, Van Marck E, Handig I, Jorens HZJ, Oostra BA, Kooy RF, Willems PJ. 1999. Post-mortem examination of two fragile X brothers with a full FMR1 mutation. Am J Med Genet 84:245-249.
35. Riddle JE, Cheema A, Sobesky WE, Gardner SC, Taylor AK, Pennington BF, Hagerman RJ. 1998. Phenotypic involvement in females with the FMR1 gene mutation. Am J Ment Retard 102:590-601.
36. Rousseau F, Heitz D, Tarleton J, MacPherson J, Malmgren H, Dahl N, Barnicoat A, Mathew C, Mornet E, Tejada I. 1994. A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB 12.3: the first 2,253 cases. Am J Hum Genet 55:225-237.
37. Schwartz CE, Dean J, Howard-Peebles PN, Bugge M, Mikkelsen M, Tommerup N, Hull C, Hagerman R, Holden JJ, Stevenson RE. 1994. Obstetrical and gynecological complications in fragile X carriers: a multicenter study. Am J Med Genet 51:400-402.
38. Smits A, Smeets D, Hamel B, Dreesen J, de Haan A, van Oost B. 1994. Prediction of mental status in carriers of the fragile X mutation using CGG repeat length. Am J Med Genet 51:497-500.
39. Snow K, Doud LK, Hagerman R, Pergolizzi RG, Erster SH, Thibodeau SN. 1993. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 53:1217-1228.
40. Sobesky WE, Porter D, Pennington BF, Hagerman RJ. 1995. Dimensions of shyness in fragile X females. Dev Brain Dysfunct 8:280-292.
41. Sobesky WE, Taylor, AK, Pennington, BF, Bennetto L, Porter D, Riddle J, Hagerman RJ. 1996, Molecular/clinical correlations in females with fragile X. Am J Med Genet 64:340-345.
42. Steyaert J, Borghgraef M, Legius E, Fryns JP. 1996. Molecular-intelligence correlations in young fragile X males with a mild CGG repeat expansion in the FMR1 gene. Am J Med Genet 64:274-277.
43. Sutherland GR, Gedeon A, Kornman L, Donnelly A, Byard RW, Mulley JC, Kremer E, Lynch M, Pritchard M, Yu S. 1991. Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence. N Engl J Med 325:1720-1722.
44. Syrrou M, Georgiou I, Patsalis PC, Bouba I, Adonakis G, Pagoulatos G. 1999. Fragile X premutation and (TA)n estrogen receptor polymorphism in woman with ovarian dysfunction. Am J Med Genet 84:306-308.
45. Tassone F, Hagerman RJ, Gane LW, Taylor AK. 1999a. Strong similarities of the FMR1 mutation in multiple tissues: postmortem studies of a male with a full mutation and a male carrier of a premutation. Am J Med Genet 84:240-244.
46. Tassone F, Hagerman RJ, Ikie D, Dyer PN, Lampe M, Willemsen R, Oostra BA, Taylor AK. 1999b. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet 84:250-261.
47. Tassone F, Longshore J, Zunich J, Steinbach P, Salat U, Taylor AK. 1999c. Tissue-specific methylation differences in a fragile X premutation carrier. Clin Genet 55:346-351.
48. Tassone F, Hagerman RJ, Taylor AK, Gane LW, Godfrey TE, Hagerman PJ. 2000. Elevated levels of FMR1 messenger RNA in carriers males: a new mechanism of involvement in the fragile X syndrome. Am J Hum Genet 66:6-15.
49. Taylor AK, Safanda JF, Fall MZ, Quince C, Lang KA, Hull CE, Carpenter I, Staley LW, Hagerman RJ. 1994. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. JAMA 271:507-514.
50. Thompson NM, Gulley ML, Rogeness GA, Clayton RJ, Johnson C, Hazelton B, Cho CG, Zellmer VT. 1994. Neurobehavioral characteristics of CGG amplification status in fragile X females. Am J Med Genet 54:378-383.
51. Turner G, Robinson H, Wake S, Martin N. 1994. Dizygous twinning and premature menopause in fragile X syndrome. Lancet 344:1500.
52. Vianna-Morgante AM. 1999. Twinning and premature ovarian failure in premutation fragile X carriers. Am J Med Genet 83:326.
53. Vianna-Morgante AM, Costa SS, Pares AS, Verreschi IT. 1996. FRAXA premutation associated with premature ovarian failure. Am J Med Genet 64:373-375.
54. Willemsen R, Mohkamsing S, de Vries B, Devys D, van den Ouweland A, Mandel JL, Galjaard H, Oostra B. 1995. Rapid antibody test for fragile X syndrome. Lancet 345:1147-1148.
55. Willemsen R, Smits A, Mohkamsing S, van Beerendonk H, de Haan A, de Vries B, van den Ouweland A, Sistermans E, Galjaard H, Oostra BA. 1997. Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique. Hum Genet 99:308-311.
56. Wohrle D, Hennig I, Vogel W, Steinbach P. 1993. Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion. Nat Genet 4:140-142.